Cargando…
BMS309403 Stimulates Glucose Uptake in Myotubes through Activation of AMP-Activated Protein Kinase
BMS309403 is a biphenyl azole inhibitor against fatty acid binding protein 4 (FABP4) and regarded as a lead compound for effective treatment of obesity related cardio-metabolic diseases. Here we discovered an off-target activity of BMS309403 in that it stimulates glucose uptake in C2C12 myotubes in...
Autores principales: | Lin, Wanhua, Huang, Xiaoli, Zhang, Lina, Chen, Dongmei, Wang, Dongye, Peng, Qilong, Xu, Lei, Li, Jingya, Liu, Xiujie, Li, Kuai, Ding, Ke, Jin, Shouguang, Li, Jia, Wu, Donghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432117/ https://www.ncbi.nlm.nih.gov/pubmed/22952994 http://dx.doi.org/10.1371/journal.pone.0044570 |
Ejemplares similares
-
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets
por: Floresta, Giuseppe, et al.
Publicado: (2018) -
FABP4 inhibitor BMS309403 protects against hypoxia‐induced H9c2 cardiomyocyte apoptosis through attenuating endoplasmic reticulum stress
por: Sun, Fuqiang, et al.
Publicado: (2020) -
The di-peptide Trp-His activates AMP-activated protein kinase and enhances glucose uptake independently of insulin in L6 myotubes
por: Soga, Minoru, et al.
Publicado: (2014) -
Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012) -
Activation of AMP-Activated Protein Kinase and Stimulation of Energy Metabolism by Acetic Acid in L6 Myotube Cells
por: Maruta, Hitomi, et al.
Publicado: (2016)